Acrivon Therapeutics, Inc. Common Stock
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder ide…
Biotechnology
US, Watertown [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Acrivon Therapeutics, Inc. Common Stock can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAcrivon Therapeutics, Inc. Common Stock can't present revenue by segment